Back to Search Start Over

Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.

Authors :
Yanagita, Motoko
Muto, Satoru
Nishiyama, Hiroyuki
Ando, Yuichi
Hirata, Sumio
Doi, Kent
Fujiwara, Yutaka
Hanafusa, Norio
Hatta, Takahiro
Hoshino, Junichi
Ichioka, Satoko
Inoue, Takamitsu
Ishikura, Kenji
Kato, Taigo
Kitamura, Hiroshi
Kobayashi, Yusuke
Koizumi, Yuichi
Kondoh, Chihiro
Matsubara, Takeshi
Matsubara, Kazuo
Source :
Clinical & Experimental Nephrology. Feb2024, Vol. 28 Issue 2, p123-124. 2p.
Publication Year :
2024

Abstract

This document is a correction notice for an article titled "Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022" published in the journal Clinical & Experimental Nephrology. The correction states that the abstract text was mistakenly included in the article and has been removed in the updated version. The original article has been corrected. The document also includes a note from the publisher, Springer Nature, stating their neutrality regarding jurisdictional claims and institutional affiliations. The article was authored by multiple individuals and their names are listed at the end of the document. [Extracted from the article]

Details

Language :
English
ISSN :
13421751
Volume :
28
Issue :
2
Database :
Academic Search Index
Journal :
Clinical & Experimental Nephrology
Publication Type :
Academic Journal
Accession number :
175006119
Full Text :
https://doi.org/10.1007/s10157-023-02436-9